Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention.
D000327:Adsorption; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D001711:Biotransformation; D002264:Carboxylic Acids / Q000494:pharmacology; D003124:Colorimetry; D004285:Dogs; D005260:Female; D005374:Filtration; D000882:Haplorhini; D006801:Humans; D007444:Inulin / Q000032:analysis; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D007684:Kidney Tubules / Q000378:metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects; D011718:Pyrazinamide / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology*; D011719:Pyrazines / Q000494:pharmacology; D014527:Uric Acid / Q000378:metabolism*; D014528:Uricosuric Agents / Q000494:pharmacology
D002264:Carboxylic Acids; D011719:Pyrazines; D014528:Uricosuric Agents; D014527:Uric Acid; D011718:Pyrazinamide; D000493:Allopurinol; D007444:Inulin